These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6342912)

  • 21. Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation.
    Morley CJ; Greenough A; Miller NG; Bangham AD; Pool J; Wood S; South M; Davis JA; Vyas H
    Early Hum Dev; 1988 May; 17(1):41-54. PubMed ID: 3061771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.
    Gortner L
    J Perinat Med; 1992; 20(6):409-19. PubMed ID: 1293266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant can be supplemented before the neonate needs it.
    Enhorning G
    J Perinat Med; 1987; 15(5):479-83. PubMed ID: 3127574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant replacement in neonatal and adult respiratory distress syndrome.
    Robertson B
    Eur J Anaesthesiol; 1984 Dec; 1(4):335-43. PubMed ID: 6549536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits.
    Johansson J; Some M; Linderholm BM; Almlén A; Curstedt T; Robertson B
    J Appl Physiol (1985); 2003 Nov; 95(5):2055-63. PubMed ID: 12897027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant respiratory therapy using Surfaxin/sinapultide.
    Lal MK; Sinha SK
    Ther Adv Respir Dis; 2008 Oct; 2(5):339-44. PubMed ID: 19124381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on lung surfactant replacement in respiratory distress syndrome. Rapid film formation from binary mixed liposomes.
    Obladen M; Popp D; Schöll C; Schwarz H; Jähnig F
    Biochim Biophys Acta; 1983 Nov; 735(2):215-24. PubMed ID: 6688738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns.
    Hallman M; Feldman BH; Kirkpatrick E; Gluck L
    Pediatr Res; 1977 Jun; 11(6):714-20. PubMed ID: 577302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged ventilation of the premature newborn rabbit after treatment with natural or apoprotein-based artificial surfactant.
    Robertson B; Curstedt T; Grossmann G; Kobayashi T; Kokubo M; Suzuki Y
    Eur J Pediatr; 1988 Feb; 147(2):168-73. PubMed ID: 3366134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial liquid ventilation in premature lambs with respiratory distress syndrome: efficacy and compatibility with exogenous surfactant.
    Leach CL; Holm B; Morin FC; Fuhrman BP; Papo MC; Steinhorn D; Hernan LJ
    J Pediatr; 1995 Mar; 126(3):412-20. PubMed ID: 7869204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Dechant KL; Faulds D
    Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with exogenous natural surfactant.
    Halliday HL
    Dev Pharmacol Ther; 1989; 13(2-4):173-81. PubMed ID: 2693000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fate of exogenous surfactant in neonates with respiratory distress syndrome.
    Hallman M; Merritt TA; Bry K
    Clin Pharmacokinet; 1994 Mar; 26(3):215-32. PubMed ID: 8194284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic treatment of very premature infants with human surfactant.
    Merritt TA; Hallman M; Bloom BT; Berry C; Benirschke K; Sahn D; Key T; Edwards D; Jarvenpaa AL; Pohjavuori M
    N Engl J Med; 1986 Sep; 315(13):785-90. PubMed ID: 3528853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trials of natural surfactant extract in respiratory distress syndrome.
    Mercier CE; Soll RF
    Clin Perinatol; 1993 Dec; 20(4):711-35. PubMed ID: 8131364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of respiratory distress syndrome in premature infants with pulmonary surfactant].
    Gortner L
    Klin Padiatr; 1989; 201(6):417-24. PubMed ID: 2689769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.